Reported May 1, 2024 · Ongoing
Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC…
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. · 224-18 · Tokushima, N/A · N/A
Is this the product you have?
- Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-007-13
- Lot codes and dates
Lot # AKS00623AExp 01/31/2026AKS00322AExp 02/28/2025
- Amount recalled
- 108,192/30 count bottles or 7 count blister packs
This recall covers 4 products
The agency filed one notice per product. You are reading one of them; the other 3 are below.
Where it was sold
- Nationwide
Why it was recalled
Cross Contamination with Other Products
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Second Tokushima Factory, Otsuka Pharmaceutical… recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.